| |
2 High-risk vaccine type*
|
4 Vaccine type*
|
14 High-risk type*
|
37 HPV type*
|
|---|
|
Correlations
|
Prespecified true Composite prevalence
|
Composite prevalence estimate§
|
Est. to true ratio
|
Prespecifiedtrue composite prevalence
|
Composite prevalence estimate§
|
Est. to true ratio
|
Prespecified true composite prevalence
|
Composite prevalence estimate§
|
Est. to true ratio
|
Prespecified true composite prevalence
|
Composite prevalence estimate§
|
Est. to true ratio
|
|---|
|
0
|
0.064
|
0.151
|
2.36
|
0.121
|
0.279
|
2.30
|
0.293
|
0.647
|
2.23
|
0.663
|
0.947
|
1.43
|
|
0.05
|
0.064
|
0.151
|
2.36
|
0.121
|
0.275
|
2.27
|
0.282
|
0.616
|
2.19
|
0.617
|
0.904
|
1.47
|
|
0.1
|
0.064
|
0.151
|
2.36
|
0.119
|
0.269
|
2.26
|
0.271
|
0.584
|
2.15
|
0.576
|
0.861
|
1.49
|
|
0.2
|
0.063
|
0.147
|
2.33
|
0.115
|
0.255
|
2.22
|
0.247
|
0.526
|
2.13
|
0.501
|
0.776
|
1.55
|
|
0.3
|
0.062
|
0.144
|
2.32
|
0.110
|
0.242
|
2.20
|
0.223
|
0.473
|
2.12
|
0.436
|
0.695
|
1.59
|
|
0.4
|
0.061
|
0.141
|
2.31
|
0.104
|
0.228
|
2.19
|
0.200
|
0.423
|
2.12
|
0.376
|
0.615
|
1.63
|
- *2: high-risk vaccine types (HPV 16, 18); 4: vaccine types (HPV 6, 11, 16, 18); 14: high-risk types (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68); 37: HPV types (HPV 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59,61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73, 81, 82, 83, 84, 89, IS39).
- Pre-specified type-specific prevalence: HPV 6 = 0.028, HPV11 = 0.034, HPV16 = 0.047, HPV18 = 0.019, HPV26 = 0.022, HPV31 = 0.015, HPV33 = 0.013, HPV35 = 0.023, HPV39 = 0.011, HPV40 = 0.018, HPV42 = 0.025, HPV45 = 0.020, HPV51 = 0.041, HPV52 = 0.036, HPV53 = 0.058, HPV54 = 0.038, HPV55 = 0.024, HPV56 = 0.023, HPV58 = 0.014, HPV59 = 0.030, HPV61 = 0.040, HPV62 = 0.065, HPV64 = 0.002, HPV66 = 0.034, HPV67 = 0.013, HPV68 = 0.016, HPV69 = 0.027, HPV70 = 0.020, HPV71 = 0.056, HPV72 = 0.012, HPV73 = 0.015, HPV81 = 0.027, HPV82 = 0.054, HPV83 = 0.041, HPV84 = 0.048, HPV89 = 0.047, HPVIS39 = 0.014.
- Pre-specified genotyping assay sensitivity = 0.95 and specificity = 0.95.
- §Standard deviations of prevalence estimates ≤0.008.
